228
Views
10
CrossRef citations to date
0
Altmetric
Extra Ocular Structures

The Effect of Solithromycin, a Cationic Amphiphilic Drug, on the Proliferation and Differentiation of Human Meibomian Gland Epithelial Cells

, , &
Pages 683-688 | Received 08 Aug 2017, Accepted 12 Dec 2017, Published online: 28 Dec 2017

References

  • Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011;52:1938–78. doi:10.1167/iovs.10-6997c.
  • Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995;113:1266–70.
  • Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930–37.
  • Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31:472–78.
  • Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52:1994–2005.
  • Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52:1922–29.
  • Sullivan DA, Tsubota K, Dartt DA, Stern ME, Sullivan RM, Bromberg BB, editors. Lacrimal gland, tear film and dry eye syndromes 3. In: Basic science and clinical relevance. New York: Kluwer Academic/Plenum Press; 2002.
  • 2007 Report of the international dry eye workshop (DEWS). Ocul Surf. 2007;5:65–204.
  • Sullivan DA, Hammitt KM, Schaumberg DA, Sullivan BD, Begley CG, Gjorstrup P, et al. Report of the TFOS/ARVO symposium on global treatments for dry eye disease: an unmet need. Ocul Surf. 2012;10:108–16.
  • Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, Barabino S, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci. 2011;52:1979–93.
  • Tsai P, Evans JE, Green KM, Sullivan RM, Schaumberg DA, Richards SM, et al. Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol. 2006;90:372–77.
  • Tiffany JM. Physiological functions of the meibomian glands. Prog Retinal Eye Res. 1995;14:47–74.
  • Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74:8–13.
  • Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78:347–60.
  • McCulley JP, Shine WE. Meibomian gland function and the tear lipid layer. Ocul Surf. 2003;1:97–106.
  • Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1:107–26.
  • Bron AJ, Sci FM, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf. 2004;2:149–65.
  • McCulley JP, Shine W. A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc. 1997;95:79–88.
  • Mathers WD, Lane JA. Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol. 1998;438:349–60.
  • Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls BD, Evans JE, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocr Metab. 2000;85:4874–82.
  • Knop E, Knop N, Brewitt H, Pleyer U, Rieck P, Seitz B, et al. [Meibomian glands: part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye]. Ophthalmologe. 2009;106:966–79.
  • Knop E, Knop N. Meibomian glands: part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD). Ophthalmologe. 2009;106:980–87.
  • Gutgesell VJ, Stern GA, Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol. 1982;94:383–87.
  • Jester JV, Nicolaides N, Kiss-Palvolgyi I, Smith RE. Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci. 1989;30:936–45.
  • Obata H. Anatomy and histopathology of human meibomian gland. Cornea. 2002;21:S70–74.
  • Sullivan BD, Evans JE, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol. 2006;124:1286–92.
  • Miyake H, Oda T, Katsuta O, Seno M, Nakamura M. Meibomian gland dysfunction model in hairless mice fed a special diet with limited lipid content. Invest Ophthalmol Vis Sci. 2016;57:3268–75.
  • Obata H, Horiuchi H, Miyata K, Tsuru T, Machinami R. [Histopathological study of the meibomian glands in 72 autopsy cases]. Nippon Ganka Gakkai Zasshi. 1994;98:765–71.
  • Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984;68:524–28.
  • Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:486–91.
  • Messmer EM, Torres SE, Mackert MI, Zapp DM, Kampik A. [In vivo confocal microscopy in blepharitis]. Klin Monatsbl Augenheilkd. 2005;222:894–900.
  • Chao W, Belmonte C, Benitez Del Castillo JM, Bron AJ, Dua HS, Nichols KK, et al. Report of the inaugural meeting of the TFOS i(2) = initiating innovation series: targeting the unmet need for dry eye treatment. Ocul Surf. 2016;14:264–316.
  • Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7:S1–S14.
  • Foulks GN, Borchman D, Yappert M, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea. 2013;32:44–53.
  • Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW. Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea. 2010;29:781–88.
  • Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O’Brien T. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2050–64.
  • Kashkouli MB, Fazel AJ, Kiavash V, Nojomi M, Ghiasian L. Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double masked open label clinical trial. Br J Ophthalmol. 2015;99:199–204.
  • Liu Y, Kam WR, Ding J, Sullivan DA. Effect of azithromycin on lipid accumulation in immortalized human meibomian gland epithelial cells. JAMA Ophthalmol. 2014;132:226–28.
  • Liu Y, Kam WR, Ding J, Sullivan DA. One man’s poison is another man’s meat. Using azithromycin-induced phospholipidosis to promote ocular surface health. Toxicology. 2014;320:1–5.
  • Anderson N, Borlak J. Drug-induced phospholipidosis. FEBS Lett. 2006;580:5533–40.
  • Sadrieh N 2010. The regulatory challenges of drug-induced phospholipidosis. FDA website http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/advisorycommitteeforpharmaceuticalscienceandclinicalpharmacology/ucm210798.pdf
  • Reasor MJ, Kacew S. Drug-induced phospholipidosis: are there functional consequences? Exp Biol Med (Maywood). 2001;226:825–30.
  • Lowe R, Mussa HY, Nigsch F, Glen RC, Mitchell JB. Predicting the mechanism of phospholipidosis. J Cheminform. 2012;4:2.
  • Liu S, Hatton MP, Khandelwal P, Sullivan DA. Culture, immortalization, and characterization of human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2010;51:3993–4005.
  • Liu S, Kam WR, Ding J, Hatton MP, Sullivan DA. Effect of growth factors on the proliferation and gene expression of human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2013;54(4):2541–50.
  • Sullivan DA, Liu Y, Kam WR, Ding J, Green KM, Shaffer SA, et al. Serum-induced differentiation of human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2014;55:3866–77.
  • Liu Y, Ding J. The combined effect of azithromycin and insulin-like growth factor-1 on cultured human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2014;55:5596–601.
  • Liu Y, Kam WR, Ding J, Sullivan DA. Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation? Cornea. 2015;34:342–46.
  • http://rsbweb.nih.gov/ij/index.html
  • Liu Y, Kam WR, Sullivan DA. Influence of omega 3 and 6 fatty acids on human meibomian gland epithelial cells. Cornea. 2016;35:1122–26.
  • Buege MJ, Brown JE, Aitken SL. Solithromycin: a novel ketolide antibiotic. Am J Health Syst Pharm. 2017;74:875–87.
  • Lemaire S, Van Bambeke F, Tulkens PM. Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against staphylococcus aureus, listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages. Antimicrob Agents Chemother. 2009;53:3734–43.
  • http://www.cempra.com/common/pdf/Posters/ICAAC% 19202010%20A1-686%20Das%20Tulkens%20CEM101%20Final%208-26-10.pdf
  • Rabionet M, Gorgas K, Sandhoff R. Ceramide synthesis in the epidermis. Biochimica Et Biophysica Acta. 2014;1841:422–34.
  • Schmitz G, Muller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res. 1991;32:1539–70.
  • Weaver TE, Na CL, Stahlman M. Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin Cell Dev Biol. 2002;13:263–70.
  • Baronas ET, Lee JW, Alden C, Hsieh FY. Biomarkers to monitor drug-induced phospholipidosis. Toxicol Appl Pharmacol. 2007;218:72–78.
  • Dietl P, Haller T, Mair N, Frick M. Mechanisms of surfactant exocytosis in alveolar type II cells in vitro and in vivo. News Physiol Sci. 2001;16:239–43.
  • Jester JV, Nicolaides N, Smith RE. Meibomian gland studies: histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci. 1981;20:537–47.
  • Sirigu P, Shen RL, Pinto Da Silva P. Human meibomian glands: the ultrastructure of acinar cells as viewed by thin section and freeze-fracture transmission electron microscopies. Invest Ophthalmol Vis Sci. 1992;33:2284–92.
  • Shayman JA, Abe A. Drug induced phospholipidosis: an acquired lysosomal storage disorder. Biochim Biophys Acta. 2013;1831:602–11.
  • El Mouedden M, Laurent G, Mingeot-Leclercq MP, Tulkens PM. Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol Sci. 2000;56:229–39.
  • Servais H, Van Der Smissen P, Thirion G, Van Der Essen G, Van Bambeke F, Tulkens PM, et al. Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol Appl Pharmacol. 2005;206:321–33.
  • Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev. 1989;69:383–416.
  • Mesquita-Guimarãtes J, Coimbra A. Holocrine cell lysis in the rat preputial sebaceous gland. Evidence of autophagocytosis during cell involution. Anat Rec. 1976;186:49–67.
  • Mesquita-Guimarãtes J, Pignatelli D, Coimbra A. Autophagy during holocrine cell lysis in skin sebaceous glands. J Submicrosc Cytol. 1979;11:435–47.
  • Brandes D, Bertini F, Smith EW. Role of lysosomes in cellular lytic processes. II. Cell death during holocrine secretion in sebaceous cells. Exp Mol Pathol. 1965;4:245–65.
  • Farrell DJ, Flamm RK, Sader HS, Jones RN. Results from the solithromycin international surveillance program (2014). Antimicrob Agents Chemother. 2016;60:3662–68.
  • http://www.cempra.com/common/pdf/posters/IDWeek% 19202012_1613_Ito_Soli%20and%20COPD_FINAL.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.